# TRILEPTAL
> **NDA021285** · New Drug Application · Sponsor: NOVARTIS · Approved 2001-05-25
## Drug
- **FDA Application Number:** NDA021285
- **Application type:** New Drug Application
- **Brand name:** TRILEPTAL
- **Generic name:** OXCARBAZEPINE
- **Active ingredients:** OXCARBAZEPINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVARTIS
- **Manufacturer:** Novartis Pharmaceuticals Corporation
- **First approval:** 2001-05-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021285)
---
*AI Analytics · CC0 1.0*